NASDAQ:SCPS Scopus BioPharma (SCPS) Stock Forecast, Price & News $0.05 0.00 (0.00%) (As of 10/2/2023 ET) Add Compare Share Share Today's Range$0.05▼$0.0650-Day Range$0.03▼$0.0752-Week Range$0.03▼$0.58Volume25 shsAverage Volume14,492 shsMarket Capitalization$1.92 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileChartCompetitorsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media About Scopus BioPharma (NASDAQ:SCPS) StockScopus BioPharma Inc., a clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases with unmet medical needs. It offers Duet Platform, which consists of signal transducer and activator of transcription 3 (STAT3), a master immune checkpoint inhibitor and toll-like receptor 9 (TLR9), as well as includes CpG-STAT3ASO (DUET-02), CpG-STAT3siRNA (DUET-01), and CpG-STAT3decoy (DUET-03); and that develops a suite of bifunctional oligonucleotides that activate antigen-presenting cells (APCs) in the tumor microenvironment that alleviates tumor immunosuppression to jump-start T cell-mediated immune responses. The company is also developing DUET-01, as a monotherapy targeting B-cell non-Hodgkin lymphoma; DUET-02 that provides systemic delivery for treatment of solid tumors comprising prostate or kidney cancers; and DUET-03, which targets the actual STAT3 transcription factor protein. Scopus BioPharma Inc. has licensing agreements with the City of Hope, National Institutes of Health Program, and The Hebrew University of Jerusalem. The company was formerly known as Project18 Inc. and changed its name to Scopus BioPharma Inc. in December 2017. Scopus BioPharma Inc. was incorporated in 2017 and is headquartered in New York, New York.Read More SCPS Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SCPS Stock News HeadlinesJuly 15, 2023 | morningstar.comKinnate Biopharma Inc Ordinary SharesMay 16, 2023 | benzinga.comScopus BioPharma Stock (OTC:SCPS), Insider Trading ActivityOctober 2, 2023 | Behind the Markets (Ad)Buy THIS stock before Taiwan is attacked... If the United States goes to war with another nuclear armed superpower, this could have a devastating impact on your retirement portfolio. Now, even Taiwan's own foreign minister is saying that China is on the cusp of a full scale invasion. But the good news is, if China invades Taiwan, there is a way to protect yourself.April 19, 2023 | morningstar.comESG Industry Landscape Report: BiopharmaMarch 18, 2023 | benzinga.comYS BIOPHARMA TO RING THE OPENING BELL AND DEBUT ON NASDAQDecember 16, 2022 | benzinga.comShort Volatility Alert: Scopus Biopharma IDecember 15, 2022 | msn.comWhy Planet Labs Shares Are Trading Higher; Here Are 28 Stocks Moving PremarketNovember 10, 2022 | finance.yahoo.comScopus BioPharma’s Subsidiary — Duet BioTherapeutics — Announces Key Scientific Data to be Presented at the 37th Annual Meeting and Exposition of the Society for Immunotherapy of CancerOctober 2, 2023 | Behind the Markets (Ad)66,000% upside on tiny biotech?The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.October 18, 2022 | finance.yahoo.comScopus Biopharma Completes Recapitalization Designed To Enhance Shareholder ValueMay 5, 2022 | finance.yahoo.comScopus BioPharma Announces Biotechnology Industry Leader Rejoins Board of DirectorsMarch 22, 2022 | finance.yahoo.comScopus BioPharma’s Subsidiary — Duet BioTherapeutics — to Present at the 3rd Annual STING & TLR-Targeting Therapies SummitJanuary 10, 2022 | finance.yahoo.comScopus BioPharma Provides Update Following Annual Meeting of StockholdersJanuary 6, 2022 | finance.yahoo.comDR. MORRIS C. LASTER WINS PROXY CONTEST AS STOCKHOLDERS ELECT HIS NOMINEES TO SCOPUS BIOPHARMA INC. BOARD OF DIRECTORSDecember 28, 2021 | nasdaq.comScopus Biopharma Inc Shares Approach 52-Week Low - Market MoverDecember 17, 2021 | finance.yahoo.comScopus BioPharma Issues Open Letter to Stockholders Detailing Morris Laster’s Campaign Against the CompanyDecember 7, 2021 | finance.yahoo.comScopus BioPharma Sends Letter Urging Stockholders to Vote “FOR ALL” of the Company’s Director Nominees on the WHITE Proxy CardDecember 6, 2021 | finance.yahoo.comDr. Morris C. Laster Issues An Open Letter To Scopus BioPharma Inc. Stockholders In Connection With Upcoming Annual MeetingNovember 22, 2021 | finance.yahoo.comScopus BioPharma Announces $9.75 Million Private Placement Priced At-The-MarketOctober 8, 2021 | finance.yahoo.comScopus BioPharma Announces Adjournment of Annual Meeting of StockholdersOctober 5, 2021 | finance.yahoo.comScopus BioPharma to Present at the LD Micro Main EventOctober 1, 2021 | finance.yahoo.comScopus BioPharma Retaining Counsel to Investigate Unusual Market ActivityOctober 1, 2021 | finance.yahoo.comScopus BioPharma to Present at MicroCap Rodeo’s Fall Harvest Best Ideas ConferenceSeptember 29, 2021 | finance.yahoo.comScopus BioPharma's Subsidiary — Duet Therapeutics — Announces Release of Preclinical Data Being Presented at 17th Annual Meeting of the Oligonucleotide Therapeutics SocietySeptember 28, 2021 | apnews.comScopus BioPharma’s Subsidiary — Duet Therapeutics — Set to Release Scientific Data During the ...September 28, 2021 | finance.yahoo.comScopus BioPharma to Adjourn 2021 Annual Meeting of StockholdersSeptember 28, 2021 | finance.yahoo.comScopus BioPharma’s Subsidiary Duet Therapeutics Set to Release Scientific Data During the 17th Annual Meeting of the Oligonucleotide Therapeutics SocietySee More Headlines Receive SCPS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Scopus BioPharma and its competitors with MarketBeat's FREE daily newsletter. Email Address SCPS Company Calendar Today10/02/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:SCPS CUSIPN/A CIK1772028 Webscopusbiopharma.com Phone212-479-2513FaxN/AEmployees13Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-11,610,000.00 Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-1,284.70% Debt Debt-to-Equity RatioN/A Current Ratio0.05 Quick Ratio0.05 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value($0.33) per share Price / Book-0.14Miscellaneous Outstanding Shares42,080,000Free Float39,938,000Market Cap$1.92 million OptionableNot Optionable Beta1.46 Beginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free Report Key ExecutivesMr. Ira Scott Greenspan (Age 64)Sr. Advisor & Director Comp: $200kMr. Robert J. GibsonVice Chairman, Sec. & TreasurerDr. Alan D. Horsager Ph.D. (Age 50)Pres?of?Immuno-Oncology and Pres & CEO of Duet BioTherapeutics Key CompetitorsAmpio PharmaceuticalsNYSE:AMPESalarius PharmaceuticalsNASDAQ:SLRXPhio PharmaceuticalsNASDAQ:PHIOAvalo TherapeuticsNASDAQ:AVTXBellicum PharmaceuticalsNASDAQ:BLCMView All Competitors SCPS Stock - Frequently Asked Questions How have SCPS shares performed in 2023? Scopus BioPharma's stock was trading at $0.0975 at the start of the year. Since then, SCPS stock has decreased by 53.1% and is now trading at $0.0457. View the best growth stocks for 2023 here. What is Scopus BioPharma's stock symbol? Scopus BioPharma trades on the NASDAQ under the ticker symbol "SCPS." How do I buy shares of Scopus BioPharma? Shares of SCPS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Scopus BioPharma's stock price today? One share of SCPS stock can currently be purchased for approximately $0.05. How much money does Scopus BioPharma make? Scopus BioPharma (NASDAQ:SCPS) has a market capitalization of $1.92 million. How can I contact Scopus BioPharma? The official website for the company is scopusbiopharma.com. The company can be reached via phone at 212-479-2513. This page (NASDAQ:SCPS) was last updated on 10/2/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Scopus BioPharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.